Rob Riemsma
Impact in
-
- Pain Management and Opioid Use
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
- Rheumatology 12
- Rheumatoid Arthritis Research and Therapies 5
- Spondyloarthritis Studies and Treatments 5
-
- Prostate Cancer Treatment and Research 3
- Advanced Breast Cancer Therapies 3
- Co-authors
- Jos Kleijnen (37 shared papers)Kate Misso (14 shared papers)Kate Light (4 shared papers)Nerys F. Woolacott (4 shared papers)Zarnie Khadjesari (3 shared papers)Gill Worthy (12 shared papers)Nigel Armstrong (22 shared papers)Mark J. Sculpher (3 shared papers)
- Journals
- PharmacoEconomics (14 papers)Health Technology Assessment (10 papers)Current Medical Research and Opinion (3 papers)BMC Cancer (1 paper)BMC Ophthalmology (1 paper)
- Partner nations
- United KingdomNetherlandsGermany
In The Last Decade
Rob Riemsma
52 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Anesthesiology and Pain Medicine 141
- Rheumatology 271
- Applied Psychology 72
- Pharmacology 182
- Economics and Econometrics 223
Countries citing papers authored by Rob Riemsma
This map shows the geographic impact of Rob Riemsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Riemsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Riemsma more than expected).
Fields of papers citing papers by Rob Riemsma
This network shows the impact of papers produced by Rob Riemsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Riemsma. The network helps show where Rob Riemsma may publish in the future.
Co-authors
The 25 scholars most cited alongside Rob Riemsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 213 | |
| 2 | 2003 | 178 | |
| 3 | 1998 | 124 | |
| 4 | 2001 | 105 | |
| 5 | 2006 | 94 | |
| 6 | Epidemiology of chronic pain and its treatment in The Netherlands. | 2011 | 79 |
| 7 | 2012 | 77 | |
| 8 | 2011 | 73 | |
| 9 | 2017 | 72 | |
| 10 | 2002 | 69 | |
| 11 | 2010 | 68 | |
| 12 | 2012 | 67 | |
| 13 | 2005 | 62 | |
| 14 | 2016 | 60 | |
| 15 | 2007 | 54 | |
| 16 | 2010 | 45 | |
| 17 | 2009 | 44 | |
| 18 | 2013 | 43 | |
| 19 | 2016 | 32 | |
| 20 | Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. | 2007 | 29 |
About Rob Riemsma
Rob Riemsma is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Anesthesiology and Pain Medicine, Economics and Econometrics and Pharmacology, having authored 52 papers that have together received 1.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Spondyloarthritis Studies and Treatments (5 papers), Pain Management and Opioid Use (4 papers), Musculoskeletal pain and rehabilitation (3 papers), Prostate Cancer Treatment and Research (3 papers), Advanced Breast Cancer Therapies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (141 citations), Rheumatology (271 citations), Applied Psychology (72 citations), Pharmacology (182 citations) and Economics and Econometrics (223 citations). Rob Riemsma has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Jos Kleijnen, Kate Misso, Kate Light, Nerys F. Woolacott, Zarnie Khadjesari, Gill Worthy, Nigel Armstrong, Mark J. Sculpher, Yolanda Bravo Vergel and Neil Hawkins. Their work appears in journals such as PharmacoEconomics, Health Technology Assessment, Current Medical Research and Opinion, BMC Cancer and BMC Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.